Clinical Trial Update: High-Dose Deferoxamine in Intracerebral Hemorrhage [Phase 2]

View source ↗

Summary

Phase 2 trial of high-dose deferoxamine for intracerebral hemorrhage was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Drugs mentioned

• Deferoxamine (deferoxamine)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Intracerebral Hemorrhage | Phase 2 | Status: TERMINATED | Results posted: 2019-05-30